326 related articles for article (PubMed ID: 23238632)
1. Replacement therapy for bleeding episodes in factor VII deficiency. A prospective evaluation.
Mariani G; Napolitano M; Dolce A; Pérez Garrido R; Batorova A; Karimi M; Platokouki H; Auerswald G; Bertrand AM; Di Minno G; Schved JF; Bjerre J; Ingerslev J; Sørensen B; Ruiz-Saez A; ;
Thromb Haemost; 2013 Feb; 109(2):238-47. PubMed ID: 23238632
[TBL] [Abstract][Full Text] [Related]
2. Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies.
Napolitano M; Di Minno MN; Batorova A; Dolce A; Giansily-Blaizot M; Ingerslev J; Schved JF; Auerswald G; Kenet G; Karimi M; Shamsi T; Ruiz de Sáez A; Dolatkhah R; Chuansumrit A; Bertrand MA; Mariani G
Haemophilia; 2016 Sep; 22(5):752-9. PubMed ID: 27338009
[TBL] [Abstract][Full Text] [Related]
3. Steps towards an effective treatment strategy in congenital factor VII deficiency.
Mariani G; Lapecorella M; Dolce A
Semin Hematol; 2006 Jan; 43(1 Suppl 1):S42-7. PubMed ID: 16427385
[TBL] [Abstract][Full Text] [Related]
4. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
Key NS; Aledort LM; Beardsley D; Cooper HA; Davignon G; Ewenstein BM; Gilchrist GS; Gill JC; Glader B; Hoots WK; Kisker CT; Lusher JM; Rosenfield CG; Shapiro AD; Smith H; Taft E
Thromb Haemost; 1998 Dec; 80(6):912-8. PubMed ID: 9869160
[TBL] [Abstract][Full Text] [Related]
5. Dosing, efficacy, and safety of recombinant factor VIIa (rFVIIa) in pediatric versus adult patients: the experience of the Hemostasis and Thrombosis Research Society (HTRS) Registry (2004-2008).
Neufeld EJ; Saxena K; Kessler CM; Cooper DL;
Pediatr Blood Cancer; 2013 Jul; 60(7):1178-83. PubMed ID: 23335449
[TBL] [Abstract][Full Text] [Related]
6. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
[TBL] [Abstract][Full Text] [Related]
7. Bleeding symptoms at disease presentation and prediction of ensuing bleeding in inherited FVII deficiency.
Di Minno MN; Dolce A; Mariani G;
Thromb Haemost; 2013 Jun; 109(6):1051-9. PubMed ID: 23571462
[TBL] [Abstract][Full Text] [Related]
8. Prevention of bleeding and hemorrhagic complications in surgical patients with inherited factor VII deficiency.
Wiszniewski A; Szczepanik A; Misiak A; Bykowska K; Szopiński P
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):324-30. PubMed ID: 25688458
[TBL] [Abstract][Full Text] [Related]
9. Congenital factor VII deficiency: therapy with recombinant activated factor VII -- a critical appraisal.
Mariani G; Konkle BA; Ingerslev J
Haemophilia; 2006 Jan; 12(1):19-27. PubMed ID: 16409171
[TBL] [Abstract][Full Text] [Related]
10. Long-term prophylaxis in severe factor VII deficiency.
Siboni SM; Biguzzi E; Mistretta C; Garagiola I; Peyvandi F
Haemophilia; 2015 Nov; 21(6):812-9. PubMed ID: 25952977
[TBL] [Abstract][Full Text] [Related]
11. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
Brenner B; Wiis J
Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
[TBL] [Abstract][Full Text] [Related]
12. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
[TBL] [Abstract][Full Text] [Related]
13. Dosing and effectiveness of recombinant activated factor VII (rFVIIA) in congenital haemophilia with inhibitors by bleed type and location: the experience of the Haemophilia and Thrombosis Research Society (HTRS) Registry (2004-2008).
Young G; Cooper DL; Gut RZ;
Haemophilia; 2012 Nov; 18(6):990-6. PubMed ID: 22631073
[TBL] [Abstract][Full Text] [Related]
14. The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency.
Huang WY; Kruskall MS; Bauer KA; Uhl L; Shaz BH
Transfusion; 2004 Nov; 44(11):1562-6. PubMed ID: 15504160
[TBL] [Abstract][Full Text] [Related]
15. Successful control of central nervous system bleeding in two newborns with severe factor VII deficiency using rFVIIa administered via Port-a-Cath.
Karimi M
Semin Hematol; 2008 Apr; 45(2 Suppl 1):S74. PubMed ID: 18544432
[TBL] [Abstract][Full Text] [Related]
16. Factor VII deficiency: defining the clinical picture and optimizing therapeutic options.
Lapecorella M; Mariani G;
Haemophilia; 2008 Nov; 14(6):1170-5. PubMed ID: 19141157
[TBL] [Abstract][Full Text] [Related]
17. Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation - the surgical STER.
Mariani G; Dolce A; Batorova A; Auerswald G; Schved JF; Siragusa S; Napolitano M; Knudsen JB; Ingerslev J;
Br J Haematol; 2011 Feb; 152(3):340-6. PubMed ID: 21158750
[TBL] [Abstract][Full Text] [Related]
18. Successful prophylactic use of recombinant activated factor VII (rFVIIa) in a patient with congenital FVII deficiency and inhibitors to FVII.
Tokgoz H; Caliskan U; Lavigne-Lissalde G; Giansily-Blaizot M
Haemophilia; 2012 Jan; 18(1):e25-7. PubMed ID: 21973016
[No Abstract] [Full Text] [Related]
19. Treatment of massive cecal bleeding in a 28-Year-old patient with homozygous factor V deficiency with activated factor VII.
Petros S; Fischer J; Mössner J; Schiefke I; Teich N
Z Gastroenterol; 2008 Mar; 46(3):271-3. PubMed ID: 18322882
[TBL] [Abstract][Full Text] [Related]
20. The paradoxical association between inherited factor VII deficiency and venous thrombosis.
Marty S; Barro C; Chatelain B; Fimbel B; Tribout B; Reynaud J; Schved JF; Giansily-Blaizot M
Haemophilia; 2008 May; 14(3):564-70. PubMed ID: 18282149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
